October 29, 2013

Helix BioPharma Corp. Annouces Fiscal 2013 Results (PDF)

Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced financial results for the year ended July
31, 2013.